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Abstract Concentrations of glutarate (GA) and its deriva-
tives such as 3-hydroxyglutarate (3OHGA), D-
(D-2OHGA) and L-2-hydroxyglutarate (L-2OHGA) are
increased in plasma, cerebrospinal fluid (CSF) and urine
of patients suffering from different forms of organic
acidurias. It has been proposed that these derivatives cause
neuronal damage in these patients, leading to dystonic and
dyskinetic movement disorders. We have recently shown
that these compounds are eliminated by the kidneys via the
human organic anion transporters, OAT1 and OAT4, and
the sodium-dependent dicarboxylate transporter 3, NaDC3.
In neurons, where most of the damage occurs, a sodium-
dependent citrate transporter, NaCT, has been identified.
Therefore, we investigated the impact of GA derivatives on
hNaCT by two-electrode voltage clamp and tracer uptake
studies. None of these compounds induced substrate-
associated currents in hNaCT-expressing Xenopus laevis
oocytes nor did GA derivatives inhibit the uptake of citrate,
the prototypical substrate of hNaCT. In contrast, D- and L-
2OHGA, but not 3OHGA, showed affinities to NaDC3,
indicating that D- and L-2OHGA impair the uptake of
dicarboxylates into astrocytes thereby possibly interfering
with their feeding of tricarboxylic acid cycle intermediates
to neurons.
Introduction
Glutaric aciduria type I is caused by deficiency of the
enzyme glutaryl CoA-dehydrogenase (GCDH) in the
metabolic pathway of lysine, hydroxylysine, and trypto-
phan, leading to an accumulation of glutaric acid (GA)
and its derivative 3-hydroxy glutaric acid (3OHGA)
(Funk et al. 2005; Harting et al. 2009; Hedlund et al.
2006; Strauss et al. 2010) in blood, cerebrospinal fluid,
and urine. 2-Hydoxyglutaric (2OHGA) acidurias are
characterized by the presence of elevated concentrations
of either L-2OHGA or its enantiomer D-2OHGA and of
α-ketoglutarate (αKG) in body fluids (Read et al. 2005;
Seiijo-Martinez et al. 2005; Struys 2006; Struys et al.
2007). Whereas L-2OHGA aciduria is caused by muta-
tions of the FAD-dependent L-2OHGA dehydrogenase
(Rzem et al. 2004), the underlying metabolic defects of D-
2OHGA aciduria are due to mutations of the enzyme
D-2-hydroxyglutarate dehydrogenase (Struys et al. 2005).
It is assumed that all GA derivatives are neurotoxins and
cause neuronal damage.
We have recently identified the sodium-dependent
dicarboxylate transporter 3 (NaDC3) and the organic anion
transporter 1 (OAT1) to be responsible for the uptake of GA
and its derivatives from the blood into renal proximal
tubular cells (Hagos et al. 2008; Mühlhausen et al. 2008).
Both transporters are also present in the human brain
(Alebouyeh et al. 2003; Bleasby et al. 2006). Whereas
OAT1 is involved in the efflux of various neurotransmitter
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metabolites from the cerebrospinal fluid to the blood across
the choroid plexus (Alebouyeh et al. 2003), NaDC3 is
restricted to astrocytes (Yodoya et al. 2006) and possibly
the choroid plexus (Pajor et al. 2001). Besides NaDC3,
another electrogenic sodium-dependent di- or tricarboxylate
transporter, hNaCT, has been identified in the brain. NaCT
is preferentially located in neurons, especially in the
hippocampus, cerebellum, cerebral cortex and olfactory
bulb (Inoue et al. 2002a, b; Wada et al. 2006; Yodoya et al.
2006). Since neuropathological findings observed in
patients suffering from glutaric aciduria type 1 as well as
from D- and L-2OHGA aciduria occur in neurons, we
investigated the impact of GA derivatives on hNaCT
expressed in Xenopus laevis oocytes.
Materials and methods
In vitro transcription of hNaCT- and hNaDC3-cRNA Capped
cRNA from the human NaCT (GenBank Accession No.
AY151833) and human NaDC3 (GenBank Accession No.
AF154121) was used as a template for cRNA synthesis.
Plasmids were linearized with Not I and in vitro cRNA
transcription was performed using the T7 mMessage
mMaschine kit (Ambion, Austin, TX, USA) according to
the manufactor’s instructions. The resulting cRNA was
suspended in purified, RNAse-free water to a final
concentration of 1 μg/μl.
Solutions A standard oocyte Ringer solution (ORi) was
used for oocyte preparation, storage, and for the uptake as
well as for the electrophysiologic measurements. ORi
contained (in mM): 110 NaCl, 3 KCl, 2 CaCl2, 5 HEPES/
Tris, adjusted to pH 7.5. Citrate, succinate, glutarate (GA),
its derivatives, 3-hydroxyglutarate (3OHGA), D- (D-
2OHGA), and L-2-hydroxyglutarate (L-2OHGA), and
glutamate were added to ORi in the concentrations
indicated in the figure legends and pH was adjusted to
7.5. All chemicals, including those for ORi, for oocyte
preparation and storage, as well as for the uptake and
electrophysiologic experiments were purchased from
Sigma-Aldrich (Taufkirchen, Germany). 3OHGA was
obtained from C. Mühlhausen (UKE, Hamburg, Germany).
Oocyte preparation and storage Stage V and VI oocytes
from Xenopus laevis (Nasco, Fort Atkinson, WI, USA) were
separated by an overnight treatment with collagenase (Typ
CLS II; Biochrom, Berlin, Germany), subsequent washings
in calcium-free ORi and maintained at 16–18°C in ORi
containing a calcium concentration of 2 mM. One day after
removal from the frog, oocytes were injected with 23 nl
cRNA coding either for hNaCT or hNaDC3, or an equivalent
amount of water (mocks) and maintained at 16–18°C in ORi
supplemented with 50 μM gentamycin and 2.5 mM sodium
pyruvate. After 3–4 days of incubation with daily medium
changes, oocytes were used for tracer uptake studies.
Transport experiments Uptake of [14C]citrate (14C[1,5]citric
acid; GE Health Care, Freiburg, Germany) or [14C]glutarate
(14C[1,5]glutaric acid; MP Biomedicals, Heidelberg,
Germany) in hNaCT- or of [14C]succinate (14C[2,3]succinic
acid; Perkin Elmer, Rodgau, Germany) in hNaDC3-
expressing oocytes was assayed at room temperature.
Inhibition of citrate uptake was determined by simultaneous
application of 12 μM 14C-citrate and ORi containing 1 mM
of GA, 3OHGA, D- or L-2OHGA, respectively, for 30 min.
14C-glutarate was used at a concentration of 20 μM.
Inhibition of succinate uptake was determined by simulta-
neous application of 18 μM 14C-succinate plus 40 μM
sodium succinate and ORi containing 1 mM glutamate. After
incubation in the respective solutions, radioactivity was
aspirated and the oocytes were washed twice in ice-cold
ORi. Oocytes were dissolved by gently shaking for 2 h in
100 μl 1 N NaOH, neutralized with 100 μl 1 N HCl, and
their 14C-contents were determined by liquid scintillation
counting (Tricarb 2900TR; Perkin Elmer). Mocks were
treated in a similar manner to serve as controls. Inhibition
experiments were performed at least in duplicate with 8–10
oocytes for each experimental condition.
Electrophysiologic analysis These studies were carried
out 3–4 days after cRNA injection at room temperature.
Oocytes were placed into a 0.5-ml chamber on the stage
of a microscope and impaled under direct view with
borosilicate glass microelectrodes filled with 3 M KCl
(BioMedical Instruments, Zöllnitz, Germany). Current-
voltage (I-V) recordings were performed using a two-
electrode voltage clamp device (OC725A; Warner,
Hambden, CT, USA) in the voltage clamp mode.
Substrate-associated currents were obtained by subtrac-
tion of the currents in the presence from those in the
absence of the substrate of interest.
Statistics and calculations Data are provided as
means±SEM. Paired Student’s t test was used to show
statistically significant difference of citrate uptake in the
absence and presence of the GA derivatives or of succinate
uptake in the absence and presence of glutamate. Statistical
significance was set at p<0.01. Michaelis-Menten constants
(KM) for 3OHGA, D- and L-2OHGA were determined by
SigmaPlot software (Systat Software, Point Richmond, CA,
USA) using the Michaelis-Menten equation I=Imax · [S]/
(KM+[S]), where I is the current, Imax is the maximum
current observed at saturating substrate concentrations, KM
is the substrate concentration at half-maximal current, and S
is the substrate concentration.
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Results
In hNaCT-expressing oocytes (5 oocytes from 4 donors),
application of 1 mM citrate led to potential-dependent
inward currents showing larger current amplitudes at
–90 mV than at more depolarizing potentials (Fig. 1a,
closed circles). The inward currents were abolished upon
substitution of all sodium by N-methyl-D-glucamine (data
not shown). In contrast to citrate, the GA derivatives
3OHGA, D-2OHGA, L-2OHGA, and GA itself, did not
evoke any potential-dependent inward currents. The indi-
vidual currents induced by these compounds were similar
in hNaCT-expressing oocytes (Fig. 1a) and in mocks
(Fig. 1b). Increasing the concentration of GA up to 5 mM
did not change this result (data not shown), indicating that
GA and GA derivatives are either not transported by hNaCT
or transport is electroneutral. To discriminate between these
possibilities, the uptake of [14C]citrate was compared to the
uptake of [14C]glutarate within 30 min in the same batch of
hNaCT-expressing oocytes (Fig. 1c). Whereas citrate uptake
increased by a factor of 3.76±0.63 (three independent
experiments) as compared to mocks, the uptake of GA in
hNaCT-expressing oocytes and in mocks was virtually
identical.
In hNaDC3-expressing oocytes (4 oocytes from four
donors), succinate (1 mM) evoked substrate-dependent
inward currents at all potentials tested (Fig. 2a, closed circles).
Subsequent application of glutamate (1 mM) did not give
rise to such currents (Fig. 2a, open circles). Neither
succinate- nor glutamate-associated currents were observed
in mocks (data not shown). In addition, succinate uptake was
only marginally inhibited by 1 mM glutamate during an
incubation time of 15 min (Fig. 2b, two independent
experiments with 8–10 oocytes per experimental condition).
At −60 mV, hNaDC3 mediates translocation of 3OHGA,
D-, and L-2OHGA with low affinity (Hagos et al. 2008).
These kinetic measurements were now extended to a broader
potential range (−90 to 0 mV), because, in the disease,
astrocytes might have lower membrane potentials and the
transporter may change its affinity to the GA derivatives. At
all potentials tested, the KM for 3OHGA was larger than the
KM for D- and L-2OHGA. Whereas the KM values for D-
and L-2OHGAwere similar and decreased with depolarizing
membrane potential, the KM for 3OHGA increased at
depolarization (Fig. 3a). The maximal currents observed for
each compound increased with hyperpolarization (Fig. 3b).
The largest current amplitudes were observed for D-2OHGA
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Fig. 1 Effects of GA derivatives on hNaCT-expressing oocytes.
Current-voltage (I-V) relations of substrate-associated currents in
hNaCT-expressing oocytes are shown in (a), (c) and mocks (b).
Oocytes were superfused first with ORi and subsequently with ORi to
which 1 mM of the respective GA derivative was added. Subtraction
of the currents obtained in the presence from those in the absence of
the respective substrate revealed the substrate-associated currents, ΔI.
Oocytes were first tested for the current induced by the prototypical
substrate, citrate, to test for successful expression and only oocytes
showing citrate-associated currents >20 nA at −90 mV were used in
this study. Afterwards, 3OHGA, D-, L-2OHGA, αKG, and GA were
applied at random order. a, b Means±SEM of 5 oocytes from 4
donors and of 3 oocytes from 3 donors, respectively. c Comparison of
the uptake of labeled citrate and glutarate in the same batch of
oocytes. Whereas the hNaCT-expressing oocytes (3 independent
experiments with 10 oocytes for each experimental condition) took
up citrate (12 μM), no uptake of glutarate (20 μM) was observed.
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(3 oocytes from 3 donors); the amplitudes measured for
3OHGA (7 oocytes from 3 donors) and L-2OHGA (6
oocytes from 5 donors) were similar in magnitude at all
potentials tested (Fig. 3b).
Discussion
To date, the brain is the only mammalian tissue from which
NaCT has been cloned (Inoue et al. 2002a, b). Subsequent
studies have shown that its expression is restricted to
neurons (Wada et al. 2006; Yodoya et al. 2006). Therefore,
we reasoned that hNaCT might be able to accept GA
derivatives which were suggested to induce the neuronal
damage observed in patients suffering from glutaric aciduria
type 1 and D, L-hydroxyglutaric aciduria. However, these
compounds neither induced substrate-associated currents nor
did they inhibit the uptake of citrate, the prototypical
substrate of hNaCT, in hNaCT-expressing oocytes. In
addition, we found no interaction of hNaCT with αKG, a
compound recently described to be taken up by neurons
(Shank and Bennett 1993). Consequently, uptake of the GA
derivatives into neurons by NaCT is not the cause of the
observed neurodegeneration.
Particularly for glutaric aciduria type 1, it is suggested
that glutaryl-CoA, GA, and 3OHGA accumulating in the
synaptic cleft is involved in the pathogenesis of the disease
(Kölker et al. 2004; Strauss et al. 2010). Because these
compounds do not readily cross the blood-brain barrier,
they accumulate within the brain (Kölker et al. 2002a, b;
Junqueira et al. 2003, 2004; Porciuncula et al. 2004; Wajner
et al. 2004; Gerstner et al. 2005; Sauer et al. 2006), where
they may inhibit the delivery of neurometabolic precursors.
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Fig. 3 Michaelis-Menten constants (KM (mM)) (a) and maximal
substrate-inducible currents (Imax (nA)) (b) of the GA derivatives as a
function of membrane potential (Vc). hNaDC3-expressing oocytes
were subsequently superfused with increasing substrate concentrations
of 3OHGA: 0.1, 0.2, 0.5, 1, 2, and 5 mM; D- and L-2OHGA: 0.01,
0.05, 0.1, 0.5, and 1 mM in ORi at pH 7.5. Values were calculated
using the SigmaPlot Systat program. Data were obtained at the end of
a 10-s perfusion with the respective solution at the indicated Vc and
were calculated from 7 oocytes of 3 donors for 3OHGA, for D-
2OHGA from 3 oocytes from 3 donors, and for L-2OHGA from 5
oocytes from 4 donors.
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Fig. 2 Effect of succinate and glutamate on hNaDC3. a Current-
voltage (I-V) relations as a function of membrane potential (Vc) in
hNaDC3-expressing oocytes were obtained by substraction of the
currents in the presence of 1 mM succinate in ORI (●) or of 1 mM
glutamate (○) in ORI from those measured in ORI alone. Data present
mean values±SEM of 4 oocytes from 4 donors. b Succinate uptake in
the absence and presence of 1 mM glutamate in hNaDC3-expressing
oocytes (black columns) and mocks (grey columns) as obtained in two
independent experiments with 8–10 oocytes for each experimental
condition. Uptake of succinate in the absence and presence of
glutamate was not significantly different.
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Due to the absence of pyruvate carboxylase (Cesar and
Hamprecht 1995; Hassel 2001), neurons lack the capacity to
perform de novo synthesis of tricarboxylic cycle constitu-
tents (TCA) and therefore depend on extracellular sources of
TCA intermediates to replenish intracellular pools of neuro-
transmitters, such as glutamate and γ-aminoisobutyrate
(GABA). Astrocytes, which in contrast to neurons, express
pyruvate carboxylase (Shank et al. 1985), play a major role
in feeding TCA constituents to the neurons. Since NaCT is
localized in neurons, we assumed that NaCT is responsible
not only for the uptake of citrate but also for the uptake of
other tri- and dicarboxylic acid derivatives into neurons.
This, however, was not the case: GA and αKG were not
accepted by NaCT.
The synaptic action of glutamate is terminated by its
uptake into astrocytes and or into presynaptic neurons.
Uptake of glutamate into astrocytes occurs by distinct
excitatory amino acid transporters (EAATs) and possibly by
low affinity sodium-dependent transport systems (Danboldt
2001; Holten et al. 2008). One such candidate transporter
may be NaDC3, recently localized to astrocytes (Yodoya et
al. 2006). However, glutamate neither induced inward
currents nor inhibited succinate uptake in hNaDC3-
expressing oocytes, and 1 mM glutamate reduced succinate
uptake only by 19.9±8.5 % (N.S.). Therefore, hNaDC3 can
be excluded as a transporter facilitating glutamate uptake
into astrocytes as opposed to recent speculation (Frizzo et
al. 2004; Holten et al. 2008).
At –60 mV, hNaDC3 carries αKG and GAwith high and
the other GA derivatives with moderate affinity (Hagos et
al. 2008). In the present study, we found that the affinities
for D- and L-2OHGA increased whereas that of 3OHGA
decreased at depolarized potentials. Besides KM, Imax was
also influenced by the membrane potential. The different
GA derivatives also differ in their Imax being largest for D-
2OHGA, indicating that D-2OHGA can be taken up into
astrocytes at high rates and may interfere with the uptake of
αKG which is needed by astrocytes for the synthesis of
glutamine (Peng et al. 1991) and other metabolic purposes.
Although our findings did not elucidate the mechanisms by
which the GA derivatives induce the neuronal damage
observed in the affected patients, we can definitely exclude
NaCT as a transporter facilitating the uptake of D- and L-
2OHGA as well as 3OHGA into neurons. The impaired
uptake of αKG due to the efficient interactions of D- and L-
2OHGA with NaDC3 could interfere with the astrocytes
ability to produce TCA derivatives and to feed neurons with
these compounds needed for synthesis of neurotransmitters.
As, during brain development, energy requirements are
increasing (Harting et al. 2009), the metabolic support of
astrocytes may be limited due to accumulating GA deriva-
tives in the synaptic cleft. This in turn may induce the
observed neuronal damage due to shortage of fuels when the
brain is in a most vulnerable phase as recently discussed by
Strauss et al. (2010).
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